Q3 2026 Arizona capital markets activity and financing insights from William & Wall analyze the quarter's equity offerings, corporate debt issuance, and private venture rounds across the state—headlined by Axon Enterprise's $1.15 billion notes offering and Opendoor's $650 million convertible. Based in Scottsdale, our investment banking firm advises Arizona business owners and issuers on sell-side Mergers & Acquisitions—combining institutional rigor with deep local market expertise.

The information reflects transactions as reported, including deal descriptions, values, and statuses, but may contain gaps, such as undisclosed deal terms or financial metrics, which limit comprehensive analysis. While efforts have been made to ensure accuracy, users should consult primary sources or professional advisors for legal, financial, or strategic decisions. No warranties are made regarding the completeness or reliability of this data, and the provider assumes no liability for its use.

Arizona - Transaction Value and Count

Reflects ECM, DCM and ROF datasets

Arizona — Overview

Arizona's capital markets in Q3 2026 reflected broad-based, well-distributed issuance across the state's financing ecosystem, with 65 transactions generating approximately $4.3 billion in disclosed capital across equity, debt, and hybrid instruments. In contrast to the first quarter's Honeywell-driven surge, Q3 featured no single outsized issuer; instead, activity was anchored by a balanced slate of large-cap debt, convertible, and follow-on equity transactions alongside a deep base of Regulation D private placements and early- and growth-stage venture rounds (50 of 65 transactions were private financings). Notable activity included Axon Enterprise's $1.15 billion notes offering, Opendoor Technologies' $650 million convertible senior notes, Arizona Public Service's $700 million two-tranche utility debt issuance, parent Pinnacle West Capital's $500 million at-the-market equity program, Trinity Capital's $350 million BDC notes, and LifeStance Health's $274.8 million follow-on—each underscoring Arizona's expanding footprint in national capital formation. Capital markets breadth also extended to new public listings, including biotech NuvOx Therapeutics' NYSE American IPO and two Nasdaq SPAC offerings (Luminous Acquisition and ARC Group Acquisition II, $105 million each), while sector participation spanned regional utilities and business development companies, real estate and fintech, defense technology, and a deep bench of healthcare-technology, biotech, and software platforms. While aggregate capital raised normalized well below the first quarter's spin-off-inflated total, transaction count held steady (65 versus 70 in Q1 2026), signaling durable, diversified access to public and institutional capital for Arizona issuers. Collectively, Q3 demonstrated resilient investor confidence, deep capital markets sophistication, and the continued integration of Arizona-based companies into the broader U.S. financing landscape.

Arizona — X / Y Plot By Sector: ECM, DCM and ROF (Venture Capital)

Reflects ECM, DCM and ROF datasets

Equity Capital Markets: Monthly Aggregate Transaction Value and Transaction Count

Debt Capital Markets: Monthly Aggregate Transaction Value and Transaction Count

Rounds of Funding (Venture Capital): Monthly Aggregate Transaction Value and Transaction Count

Arizona — Capital Markets Segmentation

Reflects ECM, DCM and ROF datasets

Arizona — Sector Breakdown

Reflects ECM, DCM and ROF datasets

Second Level Primary Industry Breakdown

Reflects ECM, DCM and ROF datasets

Arizona — Capital Markets Deal Summaries

Discern Science International, Inc. (7/1/26) - ROF - Mature - >7 Yrs Discern Science International, Inc. announced that it will receive $4,140,000 in funding on July 1, 2026. The company will issue equity pursuant to exemption provided under Regulation D, with a minimum outside investment of $10,000.
J & R Holdings XII, L.L.C. (7/1/26) - ROF - Venture - <5 Yrs J & R Holdings XII, L.L.C. announced a $2,000,000 financing on April 29, 2026. The company will issue convertible preferred shares pursuant to exemption provided under Regulation D, with a minimum outside investment of $25,000. As of July 1, 2026, the company had received $270,000 in its first tranche from four investors.
HOPE-Neuron Therapeutx, Inc. (7/2/26) - ROF - Debt - Convertible HOPE-Neuron Therapeutx, Inc. announced that it will receive $150,000 in funding on June 12, 2026. The company will issue a convertible promissory note pursuant to exemption provided under Regulation D, with a minimum outside investment of $150,000.
Flo Artificial Intelligence, Inc. (7/6/26) - ROF - Mature - >7 Yrs Flo Artificial Intelligence, Inc. announced that it will receive $13,992,757 in funding on June 26, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D.
One Raven LLC (7/7/26) - ROF - Early Stage - Seed One Raven LLC announced that it has received $5 million in a round of funding led by new investor Fifth Wall Ventures Management, LLC on July 7, 2026. The company issued convertible preferred shares, and Brendan Wallace of Fifth Wall joined the company's board of directors.
Avery Therapeutics, Inc. (7/9/26) - ROF - Venture - Series A Avery Therapeutics, Inc. announced that it will issue 7,744,519 Series A-1 preferred shares at $1.9885 per share and 2,576,279 Series A-2 preferred shares at $1.5908 per share for aggregate gross proceeds of approximately $19.5 million on July 9, 2026. The preferred shares are convertible into common shares at their original issue price and are non-redeemable. The company will receive $15.4 million pursuant to exemption provided under Regulation D.
Magic Cactus Co Inc. (7/9/26) - ROF - Debt - Non-Convertible Magic Cactus Co Inc. announced that it will receive $500,000 in funding on June 29, 2026. The company will issue non-convertible debt pursuant to exemption provided under Regulation D.
Unleashed Events LLC (7/10/26) - ROF - Early Stage - Crowdfunding Unleashed Events LLC announced a private placement of debt securities at $1 per security for minimum gross proceeds of $50,000 and maximum gross proceeds of $750,000 on July 10, 2026. The company is raising funds through crowdfunding platform Honeycomb Portal LLC under Regulation CF and will accept oversubscriptions.
Bungalows at Prairie Hills SPE LLC (7/15/26) - ROF - Venture - <5 Yrs Bungalows at Prairie Hills LLC announced that it will receive $12,500,000 in funding on July 7, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D, with a minimum outside investment of $200,000. As of July 15, 2026, the company had received $3,500,000 in its first tranche from one investor.
NuvOx Therapeutics, Inc. (7/17/26) - ECM - IPO NuvOx Therapeutics, Inc. announced an initial public offering, with common stock to list on the NYSE American under the symbol "NUOX." Underwriting discounts and commissions will be 7%, and the underwriter holds a 45-day option to purchase up to an additional 429,000 shares to cover over-allotments. Leslie Marlow and Hank Gracin of Blank Rome LLP acted as legal advisors to the company.
ProPlaintiff.ai, Inc. (7/17/26) - ROF - Venture - <5 Yrs ProPlaintiff.ai, Inc. announced that it has received a round of funding on July 17, 2026, with participation from individual investor Christopher Stark. The company issued convertible preferred stock in the transaction.
Health Endeavors, LLC (7/22/26) - ROF - Debt - Non-Convertible Health Endeavors, LLC announced that it has raised funding on July 22, 2026, with participation from new lender Decathlon Capital Partners, LLC. The company issued non-convertible debt in the transaction.
Intelligent Clinical Systems, Inc. (7/22/26) - ROF - Early Stage - Crowdfunding Intelligent Clinical Systems, Inc. announced a private placement of SAFE securities at $1 each for minimum gross proceeds of $50,000 and maximum gross proceeds of $1,235,000 on July 22, 2026. The company is raising funds through crowdfunding platform Wefunder Portal LLC under Regulation CF and will accept oversubscriptions.
HOPE-Neuron Therapeutx, Inc. (7/30/26) - ROF - Early Stage - Crowdfunding HOPE-Neuron Therapeutx, Inc. announced a private placement of a minimum of 75,000 and a maximum of 5,000,000 common shares at $1 per share for maximum gross proceeds of $5,000,000 on July 30, 2026. The company is raising funds through crowdfunding platform OpenDeal Portal LLC under Regulation CF and will accept oversubscriptions.
OralKleen, LLC (7/30/26) - ROF - Early Stage - Seed OralKleen, LLC announced that it will issue four series of seed preferred shares for aggregate gross proceeds of $3,129,341 on July 28, 2026, at a post-money valuation of $8,536,809. The preferred shares are convertible into common shares at their original issue price, issued pursuant to exemption provided under Regulation D. As of September 17, 2026, the company had received $300,000 in its first tranche from a single investor.
Shared Practices Group, LLC (7/31/26) - ROF - Venture - <5 Yrs Shared Practices Group, LLC announced that it has raised a round of funding on July 31, 2026, with participation from new investor M-One Capital Management, LLC. The company issued common stock, with Solomon Partners acting as financial advisor and BakerHostetler as legal advisor.
AZJAH41 LLC (8/3/26) - ROF - Venture - <5 Yrs AZJAH41 LLC announced that it will receive $75,721 in funding on June 18, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D. As of August 3, 2026, the company had received $75,360 in its first tranche from two investors.
CND Life Sciences, Inc. (8/4/26) - ROF - Mature - >7 Yrs CND Life Sciences, Inc. announced that it has received a round of funding led by returning investor S-Curve Partners on August 4, 2026, with participation from other returning investors. The company issued convertible preferred shares in the transaction.
King Global Ventures Inc. (8/4/26) - ECM - Follow-on King Global Ventures Inc. announced a non-brokered private placement of 5,750,000 units at $0.40 per unit for gross proceeds of $2,300,000 on August 4, 2026. Each unit consists of one common share and one warrant exercisable at $0.75 for two years. The placement is subject to Canadian Securities Exchange approval.
Luminous Acquisition (8/4/26) - ECM - IPO Luminous Acquisition announced a $105 million SPAC initial public offering of units, each consisting of one Class A ordinary share, one redeemable warrant, and one right to a quarter-share upon an initial business combination. The company intends to list on the Nasdaq Global Market under the symbol "LUMIU." The underwriters hold a 45-day option to purchase up to an additional 1,575,000 units to cover over-allotments.
Pinnacle West Capital Corporation (8/4/26) - ECM - Follow-on Pinnacle West Capital Corporation entered into an equity distribution agreement with a syndicate of managers—including BMO Capital Markets, Citigroup, Morgan Stanley, RBC Capital Markets, and others—to sell up to $500,000,000 of common stock at prevailing market prices. The managers are entitled to compensation of up to 1% of aggregate gross sales.
Gentle Weapons (8/5/26) - ROF - Early Stage - Pre-Seed Gentle Weapons announced that it has received $200,000 in a round of funding on June 15, 2026, with participation from new investor Antler Innovation Pte. Ltd. The company issued convertible preferred shares in the transaction.
MiiHealth Corporation (8/5/26) - ROF - Early Stage - Seed MiiHealth (MiiHealth AI) announced that it has received $2.8 million in a round of funding led by new individual investor Russell Glass on August 5, 2026. The round included a group of physician angels, healthcare operators, and digital-health founders. The company issued convertible preferred shares in the transaction.
ARC Group Securities Acquisition I (8/6/26) - ROF - Growth - Series 5-7 Yrs ARC Group Securities Acquisition I announced a purchase agreement for 140,000 units at $10 each for gross proceeds of $1,400,000 from new investor FDB I LLC on August 5, 2026. Each unit consists of one Class A ordinary share, one right to a quarter-share upon an initial business combination, and one redeemable warrant exercisable at $11.50.
Orenda Foods (SPV) Inc. (8/6/26) - ROF - Venture - <5 Yrs Orenda Foods (SPV) Inc. announced that it will receive $1,154 in funding on July 23, 2026. The company issued convertible preferred stock pursuant to exemption provided under Regulation D. The transaction closed on August 6, 2026 with participation from two investors.
Flora Coatings, Inc. (8/7/26) - ROF - Venture - <5 Yrs Flora Coatings, Inc. announced that it will receive $800,000 in funding on July 9, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D, with a minimum outside investment of $800,000.
Western Waste Haulers Inc. (8/7/26) - ROF - Venture - <5 Yrs Western Waste Haulers Inc. announced that it will receive $290,000 in funding on August 4, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D. As of August 7, 2026, the company had received $240,000 in its first tranche from three investors.
Arizona Public Service Company (8/10/26) - DCM - Non-convertible Debt Arizona Public Service Company announced $100 million of 5.50% Notes due 2035, which traded on August 10, 2026 and settled on August 13, 2026 at a yield to maturity of 5.548% and a treasury spread of +85 basis points. Interest is payable semi-annually on March 1 and September 1. The notes were issued concurrently with $600 million of 6.25% Notes due 2056.
Arizona Public Service Company (8/10/26) - DCM - Non-convertible Debt Arizona Public Service Company announced $600 million of 6.25% Notes due 2056, which traded on August 10, 2026 and settled on August 13, 2026 at a yield to maturity of 6.321% and a treasury spread of +107 basis points. Interest is payable semi-annually on February 15 and August 15, beginning February 15, 2027. The notes were issued concurrently with $100 million of 5.50% Notes due 2035.
NantOptiFab, Inc. (8/10/26) - ROF - Venture - Series A NantOptiFab, Inc. announced that it will issue 1,333,500 Series A preferred shares at $7.4991 per share and 2,400,300 Series A-1 preferred shares at $8.3323 per share for aggregate gross proceeds of $30,000,070 on August 10, 2026. The preferred shares are convertible into common shares at their original issue price and are non-redeemable, issued pursuant to exemption provided under Regulation D.
Kore Holding Group, LLC (8/12/26) - ROF - Venture - <5 Yrs Kore Holding Group, LLC announced that it will receive $500,000 in funding on June 16, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D.
CD Concepts LLC (8/13/26) - ROF - Venture - <5 Yrs CD Concepts LLC (Comenta Corp) announced that it will receive $1,500,000 in funding on August 8, 2026. The company will issue debt pursuant to exemption provided under Regulation D. As of August 13, 2026, the company had received $10,000 in its first tranche from one investor.
Opendoor Technologies Inc. (8/13/26) - ECM - Convertible Opendoor Technologies Inc. announced $650 million of 0% convertible senior notes due 2030, expected to settle on August 19, 2026, alongside a concurrent repurchase of approximately 45.3 million shares for $158 million. The notes carry an initial conversion rate of 212.2466 shares per $1,000 principal amount (an initial conversion price of approximately $4.71, a 35% premium to the $3.49 August 12 closing price).
PointsKash Inc. (8/13/26) - ROF - Growth - Series 5-7 Yrs PointsKash Inc. announced that it will receive $100 million in a round of funding led by new investor Hawk Capital Investors, LLC on August 13, 2026. The company issued convertible preferred stock, with up to $35 million of capital available through October 30, 2026 and up to an additional $65 million from February through April 2027, subject to operating and deployment milestones.
ServBanc Holdco, Inc. (8/14/26) - ROF - Debt - Non-Convertible ServBanc Holdco, Inc. announced that it has raised $90 million on August 13, 2026 from more than 45 investors, including banks, insurance companies, and other institutions. The company issued 7.00% Fixed-to-Floating Rate Subordinated Notes due 2036 pursuant to exemption provided under Regulation D. Performance Trust Capital Partners acted as placement agent and Hunton Andrews Kurth as legal advisor.
nlitenai, inc (8/17/26) - ROF - Venture - <5 Yrs nlitenai, inc announced that it will receive $2,000,000 in funding on August 4, 2026. The company will issue SAFE securities pursuant to exemption provided under Regulation D, with a minimum outside investment of $25,000. As of August 17, 2026, the company had received $25,000 in its first tranche from one investor.
STRIX AI, Inc. (8/18/26) - ROF - Venture - <5 Yrs STRIX AI, Inc. announced that it will receive $60,000 in funding on July 7, 2026. The company will issue SAFE securities pursuant to exemption provided under Regulation D.
ARC Group Acquisition II Corp. (8/20/26) - ECM - IPO ARC Group Acquisition II Corp. announced a $105 million SPAC initial public offering of units at $10.00 each, each consisting of one Class A ordinary share, one right to a quarter-share upon an initial business combination, and one redeemable warrant exercisable at $11.50. The company intends to list on the Nasdaq Global Market under the symbol "CLMZU." Sponsor MFH 3, LLC committed to purchase 140,000 private units for $1,400,000.
Global Water Resources, Inc. (8/21/26) - ECM - Follow-on Global Water Resources, Inc. entered into a securities purchase agreement to issue 1,129,944 common shares at $8.85 per share for gross proceeds of $10,000,004 on August 20, 2026. Participants included Levine Investments LP, Andrew M. Cohn, and Verde Investments Inc. The transaction was exempt under Section 4(a)(2) and Rule 506.
Navajo Poly LLC (8/24/26) - ROF - Venture - <5 Yrs Navajo Poly LLC announced that it will receive $1,000,000 in funding on August 24, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D. As of August 24, 2026, the company had received $561,300 in its first tranche from 27 non-accredited investors.
Geviti, Inc. (8/25/26) - ROF - Venture - Series A Geviti, Inc. announced that it will raise $10,400,000 on August 25, 2026, issuing 800,000 Series A preferred shares at $13 per share at a post-money valuation of $10.4 million. The shares are convertible, non-redeemable, and non-cumulative, issued pursuant to exemption provided under Regulation D. As of September 15, 2026, the company had received $1,609,972 from five investors.
ImageAiD, Inc. (8/27/26) - ROF - Venture - <5 Yrs IMAGEAID, INC. announced that it has received funding on August 18, 2026, with participation from new investor Jetstream Venture Fund, co-managed by Sweater Industries LLC and Xcellerant Ventures, LLC. The company issued convertible preferred shares in the transaction.
Neuro-Vascular Research & Design Corp (8/31/26) - ROF - Mature - >7 Yrs Neuro-Vascular Research & Design Corp announced that it will receive $50,000 in funding on August 26, 2026. The company will issue SAFE securities pursuant to exemption provided under Regulation D.
Idealab AZ, Inc. (9/2/26) - ROF - Mature - >7 Yrs Idealab AZ, Inc. announced that it will receive $1,250,000 in funding on August 18, 2026. The company will issue restricted common shares and convertible preferred stock pursuant to exemption provided under Regulation D. The transaction closed on August 28, 2026 with participation from three investors.
Big Auto - Accident Attorneys PLLC (9/4/26) - ROF - Venture - <5 Yrs Big Auto - Accident Attorneys PLLC announced that it will receive $2,500,000 in funding on August 21, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D. As of September 4, 2026, the company had received $2,300,000 in its first tranche from six investors.
Fold Holdings, Inc. (9/8/26) - ECM - Follow-on Fold Holdings, Inc. entered into a common stock purchase agreement to issue common shares for gross proceeds of up to $25,000,000 on September 4, 2026, with participation from new investor Roth Principal Investments, LLC. The company may sell shares at its discretion over a 36-month period and will pay a $500,000 commitment fee, with shares issued under Regulation D.
LifeStance Health Group, Inc. (9/9/26) - ECM - Follow-on LifeStance Health Group, Inc. announced a follow-on offering in which it intends to purchase 2,000,000 shares from the underwriter at the price paid to the selling stockholders. The offering and repurchase were expected to settle on or about September 11, 2026.
Sparkle Franchising, LLC (9/9/26) - ROF - Venture - <5 Yrs Sparkle Franchising, LLC announced that it has received $6 million in a round of funding led by new investor Companion Fund, co-managed by Mars Petcare and Digitalis Ventures, on September 9, 2026. The company issued convertible preferred shares in the transaction.
HFO-Geviti SPV, LLC (9/10/26) - ROF - Venture - <5 Yrs HFO-Geviti SPV, LLC announced that it will receive $8,000,000 in funding on September 1, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D, with a minimum outside investment of $25,000. As of September 10, 2026, the company had received $940,000 in its first tranche from ten investors.
Koantek LLC (9/10/26) - ROF - Venture - <5 Yrs Koantek (Koantek Holdings, Inc.) announced that it will receive $6,999,997 in funding on May 6, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D.
Kaiser Garage Doors and Gates, Inc. (9/11/26) - ROF - Venture - <5 Yrs Kaiser Garage Doors and Gates, Inc. announced that it has received funding from new investor CID Capital Opportunity Fund IV, L.P., a fund managed by CID Capital, Inc., on September 11, 2026. The company issued convertible preferred shares, with XLCS Partners acting as advisor.
Aspire Group Ltd. (9/14/26) - ROF - Venture - <5 Yrs Aspire Group Ltd. (Blush Boy Corp.) announced that it will receive $1,000,000 in funding on September 9, 2026. The company will issue SAFE securities along with options or warrants pursuant to exemption provided under Regulation D. As of September 14, 2026, the company had received $100,000 in its first tranche from a single investor.
AZJAH42 LLC (9/14/26) - ROF - Venture - <5 Yrs AZJAH42 LLC announced that it will receive $750,185 in funding on August 12, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D, with a minimum outside investment of $20,000. As of September 14, 2026, the company had received $724,819 in its first tranche from eleven investors.
Axon Enterprise, Inc. (9/15/26) - DCM - Non-convertible Debt Axon Enterprise, Inc. announced $1.15 billion of notes, priced September 16, 2026 and issued September 18, 2026, carrying an initial conversion rate of 1.5336 shares of common stock per $1,000 principal amount. The underwriters hold an 11-day option to purchase up to an additional $150 million aggregate principal amount of notes to cover over-allotments.
Datavant, Inc. (9/15/26) - ROF - Mature - >7 Yrs Datavant, Inc. announced a round of funding on September 15, 2026 with participation from new investors managed by Neuberger Berman and KKR, alongside returning investor New Mountain Capital, which retains its control position. The company will issue common stock, with the transaction expected to close in Q4 2026. J.P. Morgan acted as sole placement agent and lead financial advisor.
Mainstay Labs Inc. (9/16/26) - ROF - Growth - Series 5-7 Yrs Mainstay Labs Inc. announced that it has received more than $18 million in a round of funding on September 16, 2026. The round included new investors Parker89, Stackpoint Ventures, Alpaca VC, and FJ Labs, alongside returning investors Khosla Ventures, Era Ventures, and Clocktower Technology Ventures. The company issued convertible preferred stock in the transaction.
GACW Incorporated (9/17/26) - ROF - Early Stage - Crowdfunding GACW Incorporated announced a private placement of a minimum of 5,060 and a maximum of 681,413 common shares at $3.95 per share for maximum gross proceeds of $2,691,581 on September 17, 2026. The company is raising funds through crowdfunding platform StartEngine Primary, LLC under Regulation CF and will accept oversubscriptions.
LifeGuides, PBC (9/18/26) - ROF - Mature - >7 Yrs LifeGuides, PBC announced that it has received funding on September 18, 2026, with participation from new investor the Society for Human Resource Management. The company issued convertible preferred shares in the transaction.
Brite Bird LLC (9/22/26) - ROF - Venture - <5 Yrs Brite Bird LLC announced that it will receive $84,741 in funding on September 15, 2026. The company will issue convertible preferred stock pursuant to exemption provided under Regulation D.
Dr. Better Sleep, Inc. (9/22/26) - ROF - Venture - <5 Yrs Dr. Better Sleep, Inc. announced that it will receive $335,000 in funding on July 13, 2026. The company will issue SAFE securities pursuant to exemption provided under Regulation D. As of September 22, 2026, the company had received $20,000 in its first tranche from two investors.
Monetary Metals & Co. (9/22/26) - ROF - Mature - >7 Yrs Monetary Metals & Co. announced that it has received $10.5 million in a round of funding on September 22, 2026, with participation from existing shareholders, new shareholders, and strategic investors. The company issued convertible equity in the transaction.
VPP WHS LLC (9/28/26) - ROF - Venture - <5 Yrs VPP WHS LLC announced that it will receive $200,000 in funding on August 31, 2026. The company will issue equity pursuant to exemption provided under Regulation D.
Liberty Star Uranium & Metals Corp. (9/29/26) - ECM - Convertible Liberty Star Uranium & Metals Corp. entered into a securities purchase agreement with new investor Monroe Street Capital Partners, LP to issue an 8% convertible promissory note with a principal amount of $95,700 at a 10% original issue discount for gross proceeds of $87,000 on September 21, 2026. The note matures one year from issuance, with Moody Capital Solutions acting as placement agent.
Leslie's, Inc. (9/30/26) - ECM - Follow-on Leslie's, Inc. announced a private placement of common shares for gross proceeds of $60,000,000 on September 30, 2026.
Trinity Capital Inc. (9/30/26) - DCM - Non-convertible Debt Trinity Capital Inc. announced a $350 million non-convertible notes offering that traded on September 30, 2026 and settled on October 5, 2026 at a yield to maturity of 7.714% and a treasury spread of +262.5 basis points. Interest is payable semi-annually on January 15 and July 15, beginning January 15, 2027.

Capital Markets Segmentation — Glossary:

Equity Capital Markets

Follow-on: A public issuance of additional shares by a listed company to raise capital.
Convertible: Issuing equity-linked securities that can convert into common shares, blending debt and equity.

Debt Capital Markets

Non-convertible Debt: Fixed-income securities issued to raise capital, without equity conversion.
Preferred Equity: Shares with fixed dividends and priority over common equity, without conversion.

Rounds of Funding

Early Stage - Pre-Seed: Early startup investment for ideation or initial setup.
Early Stage - Crowdfunding: Raising small capital amounts from many investors via online platforms.
Early Stage - Seed: Initial startup investment for product development or market entry.
Venture - <5 Yrs: Early-stage investment in startups less than five years old for growth.
Mature - >7 Yrs: Capital raised by established companies over seven years old for expansion.
Debt - Convertible: Private debt that converts to equity, often for startups.
Debt - Non-Convertible: Private debt financing that doesn’t convert to equity, funding operations.

Q3 2026 | Arizona Debt, Equity & Venture Capital Insights

Q3 2026 | Arizona M&A Insights

Q2 2026 | Arizona M&A Insights